Oregon Bioscience Association
June 16, 2011
Calendar of Events 2011 Read More
State Info
Oregon Economic Impact Study
June 16, 2011
A new economic impact study shows biotechnology, life sciences and medical research contribute billions of dollars in direct revenue to Oregon’s economy, and local biotech workers earn higher wages. Read More
Oregon Economic Impact Study
June 16, 2011
A new economic impact study shows biotechnology, life sciences and medical research contribute billions of dollars in direct revenue to Oregon’s economy, and local biotech workers earn higher wages. Read More
Economic Impact of Oregon Health Sciences University
June 16, 2011
Oregon Health & Science University (OHSU) is the state’s only academic health center, and is among the state’s largest healthcare providers, educational institutions, research centers and employers. OHSU’s health and economic impacts are substantial, and while its activities are centered in the Portland metropolitan area, its impact reaches throughout the state. Read More
2010 Oregon Bio Annual Report
June 16, 2011
The Oregon Bioscience Association is pleased to share industry updates, benchmarks, strategy and milestones in its 2010 Annual Report on Community, Collaboration and Commercialization. Throughout 2010, Oregon’s bioscience industry remained an economic bright spot. Despite this less than ideal environment, Oregon Bio made steady, measurable progress in building a solid financial foundation for future growth. […]
Bio in Oregon
June 16, 2011
Oregon’s bioscience industry is recognized for its contributions to the health and well-being of our people, and there is a growing awareness of its positive impact on our state’s economy and on each community in which bioscience companies and institutions operate. Read More
Life Sciences Leadership Summit
June 15, 2011
June 15, 2011 Washington State University Spokane, WA Read More
Washington State Preferred Drug List and the Therapeutic Interchange Program (TIP)
June 15, 2011
The Therapeutic Interchange Program (TIP) has developed a process allowing physicians and other prescribers to endorse the Washington State Preferred Drug List (PDL), and requires pharmacists to automatically substitute the preferred drug for non preferred drugs prescribed by these practitioners unless the prescription is for a refill of an antipsychotic, antidepressant, chemotherapy, antiretroviral, or immunosuppressive […]
Washington State Legislature – Therapeutic Interchange Program
June 15, 2011
This section contains the department’s rules for the endorsing practitioner therapeutic interchange program (TIP). TIP is established under RCW. The statutes require state-operated prescription drug programs to allow physicians and other prescribers to endorse a Washington preferred drug list (PDL) and, in most cases, requires pharmacists to automatically substitute a preferred, equivalent drug from the […]
